Head Value Based Partnership & Digital innovation Health Europe | Amgen EIT Health Core Member
Risch-Rotkreuz, Zug, Switzerland
follow me on @davdellamonica #patient #innovation @Sanofi #Pcsk9 launch unit | #ehealth #epatient #digitalhealth #cvriskscreener #healthdata | Tweets are my own @davdellamonicaHead of Global PCSK9 Patient Advocacy and Innovation @ PCSK9 Development and Launch Unit From May 2014 to Present (1 year 8 months) Paris Area, FranceDirector, Patients Solutions and Innovation - PCSK9 @ From March 2013...
follow me on @davdellamonica #patient #innovation @Sanofi #Pcsk9 launch unit | #ehealth #epatient #digitalhealth #cvriskscreener #healthdata | Tweets are my own @davdellamonicaHead of Global PCSK9 Patient Advocacy and Innovation @ PCSK9 Development and Launch Unit From May 2014 to Present (1 year 8 months) Paris Area, FranceDirector, Patients Solutions and Innovation - PCSK9 @ From March 2013 to Present (2 years 10 months) Paris Area, FranceFounder @ Expanding Patient-Centered Care Strategy To Empower Patients and Assist Providers From June 2012 to Present (3 years 7 months) Co-founder VP @ The French Crohn's and Colitis Foundation “A rope for hope” is a non-profit, volunteer-driven organization dedicated to finding the cure with innovation for Crohn's disease and ulcerative colitis. It was founded in 2008 by Eric Balez, Pr Xavier Hebuterne MD and David Dellamonica. Educational workshops and symposia with the movie “un Mont Blanc pour y croire” (Cannes film selection) and the comics “la cordee du Mont Rose”.... In collaboration with AFA From 2008 to Present (7 years) FranceBoard member @ Eurobiomed is a non-for-profit organisation which has been accredited by the French government as a "healthcare competitive cluster" From June 2012 to 2014 (2 years) Coordination working group > relationship between patients association and pharmacos @ RARE2013 « L'innovation et les partenariats au service des malades » l’atelier A1 : Relations associations de malades et industrie : suivi de l'atelier de RARE 2011 http://www.rare2013.com From June 2013 to December 2013 (7 months) Montpellier Area, FranceCEO Co-founder @ Theralpha is a leading specialty Biopharmaceutical company focused on the development of innovative non-opioide therapies for pain treatment. Mambalgins - THA904 "Black mamba venom peptides target acid-sensing ion channels to abolish pain." Nature advance online publication.Diochot, S., A. Baron, et al. (2012) From August 2009 to March 2013 (3 years 8 months) Strategic Development Director @ TxCell has developed a unique proprietary, breakthrough technology platform, using type 1 regulatory T cells ( TxCell is dedicated to the development of therapeutic products for severe chronic inflammatory and autoimmune diseases with high unmet medical need including inflammatory bowel diseases, inflammatory joint diseases and neurological diseases such as Multiple Sclerosis. The product candidates developed by TxCell consist of antigen-specific Type 1 regulatory cells (Ag-Tregs) generated ex-vivo from patient's peripheral blood in a proprietary manufacturing process. From March 2007 to August 2009 (2 years 6 months) Director and founder of Life Sciences Department @ From October 2003 to March 2007 (3 years 6 months) Nice Area, FranceLife Sicences Business Developpment Manager @ From 2000 to 2003 (3 years) Marketing Manager Virologie, Cardiologie @ From 1998 to 2000 (2 years) Paris Area, FranceMBA @ MBA From 2006 to 2007 Bachelors @ Ecole supérieure de Gestion From 1995 to 1998 The chronic Disease Self-Management Program @ Stanford University School of Medicine David Dellamonica is skilled in: Life Sciences, Clinical, Clinical Development, Commercialization, Treatment, Pharmaceuticals, Technology Transfer, Biotechnology, Forecasting, Product Development, Business Strategy, Biopharmaceuticals, Patents, Licensing, Strategy Development
Head of Global PCSK9 Patient Advocacy and Innovation
May 2014 to Present
Paris Area, France
Director, Patients Solutions and Innovation - PCSK9
March 2013 to Present
Paris Area, France
June 2012 to Present
The French Crohn's and Colitis Foundation “A rope for hope”
2008 to Present
June 2012 to 2014
Coordination working group > relationship between patients association and pharmacos
June 2013 to December 2013
Montpellier Area, France
August 2009 to March 2013
Strategic Development Director
March 2007 to August 2009
Team Cote D’Azur
Director and founder of Life Sciences Department
October 2003 to March 2007
Nice Area, France
Life Sicences Business Developpment Manager
2000 to 2003
Mediactiv / New&Com
Marketing Manager Virologie, Cardiologie
1998 to 2000
Paris Area, France
What company does David Dellamonica work for?
David Dellamonica works for Sanofi
What is David Dellamonica's role at Sanofi?
David Dellamonica is Head of Global PCSK9 Patient Advocacy and Innovation
What industry does David Dellamonica work in?
David Dellamonica works in the Biotechnology industry.
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies